Developer docs
API playgroundTry for free, no card

Search company profiles

APOVERLAG

Full company profile

uuid000kwnc

Namestring
APOVERLAG
Legal namestring
Österreichische Apotheker-Verlagsgesellschaft m.b.H.
Websiteurl
apoverlag.at
Company typeenum
Private
Founded yearint
1946
Descriptiontext

APOVERLAG (legal name: Österreichische Apotheker-Verlagsgesellschaft m.b.H.) is a Vienna-based, privately held publishing and information services company serving the Austrian pharmaceutical sector. Founded in 1946 and jointly owned 50/50 by the Österreichischer Apothekerverband and the Verband Angestellter Apotheker Österreichs (VAAÖ), the company operates three brands—ApoVerlag, AustriaCodex, and Diagnosia—that collectively cover the pharmacy-to-physician-to-hospital value chain. Its core assets include AVS Software (Austria's leading pharmacy management system), Diagnosia Enterprise (a web-based clinical decision support platform serving 90+ hospitals and nursing facilities with 7M+ monthly data queries), and the Austria Codex Online pharmaceutical database covering 110,000+ drug articles.

The company's technology stack comprises cloud-hosted web applications and mobile apps integrating with hospital KIS/PDMS systems via documented REST-API (JSON) and GET-parameter interfaces. Diagnosia Enterprise sources clinical evidence from Medbase (a Karolinska Institut spin-off, ISO-certified), AGES, and EMA. The portfolio also includes professional journals (ÖAZ, pka-Magazin, DA – Deine Apotheke), continuing education platforms (ApoVerlag Campus, Diagnosia Campus), print reference works (Taxbehelf, Warenverzeichnis), the ApoShop e-commerce storefront, and the ApoVerlag Couponing system operating across 1,400+ pharmacy interfaces.

APOVERLAG generates revenue through six distinct streams: recurring database and software subscriptions (Austria Codex Online, Diagnosia Enterprise, AVS Software), software licenses and SaaS, print publications, direct e-commerce product sales via ApoShop, advertising in owned professional media, and freemium training/continuing education. Go-to-market combines direct-to-consumer self-service through ApoShop, in-house enterprise sales (Verkaufsabteilung) for AVS and Diagnosia Enterprise, certified software house partners for hospital integration, and the association ownership structure that delivers near-universal distribution across the Austrian pharmacy profession. The company serves four primary vertical segments—pharmacies, physician practices, hospitals, and pharmaceutical companies—exclusively within the Austrian domestic market.

Short descriptiontext

APOVERLAG is a Vienna-based, pharmacist-association-owned publishing and information services company (founded 1946) providing pharmacy software (AVS), clinical decision support for 90+ hospitals (Diagnosia Enterprise), pharmaceutical databases, professional journals, and continuing education to the Austrian healthcare sector.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBreitenfurt Bei Wien, Austria
HQ citystring
Breitenfurt Bei Wien
HQ countrystring
Austria
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical information databases, pharmacy management software, clinical decision support systems, medical publishing services, healthcare professional education
Industry4 codes
PRIMARYHLALAIAD
ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALAIAG
Medication Adherence & Therapy Management Platforms (refills, reminders, MTM)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLACAKAN
Medication Pricing, Copay Assistance & Patient Financial Support Tools
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYMPAAAAAJ
Healthcare/Pharma Creative Agencies
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Advertising Agencies (Full-Service/Creative)
NAICS code1 code
  • Software Publishers51321
Product category
Pharmaceutical Information & Pharmacy Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model6 records
1Pharmaceutical Database Subscriptions
TypeSubscription Recurring
Description

Subscription-based access to Austria Codex Online, Austria Codex KHIX², Warenverzeichnis Online, AMSE, and other pharma databases. Offered as modular, combinable subscriptions for pharmacies, hospitals, physician practices, and pharmaceutical companies. Revenue is recurring with periodic (monthly/annual) billing.

apoverlag.at
2Software Licenses and SaaS
TypeSubscription Recurring
Description

Licensing of AVS Software (pharmacy management), Diagnosia Enterprise (clinical decision support), and AVS One App. Diagnosia Enterprise is offered as standalone or integrated solutions for hospitals, with tiered modules (Basic, Check, Grav&Lact, Allergy, Dose).

apoverlag.at
3Print Publications and Journals
TypeSubscription Recurring
Description

Sale of pharmaceutical journals (ÖAZ – Österreichische Apotheker-Zeitung, appearing bi-weekly; pka-Magazin, appearing six times annually; DA – Deine Apotheke customer magazine), pharmaceutical reference works (Taxbehelf, Warenverzeichnis print editions, pharmaceutical handbooks), and prescription reference tables. Offered as subscriptions or individual purchases.

apoverlag.at
4eCommerce – Product Sales
TypeOne Time License
Description

Direct sales of pharmacy supplies, consumables, packaging, reference tables, handbooks, and pharmaceutical documentation through the ApoShop online store (shop.apoverlag.at). Includes one-time purchases and consumable restocking.

apoverlag.at
5Advertising and Promotion Services
TypeAdvertising
Description

Advertising and promotional placement in print journals (ÖAZ, pka-Magazin, DA – Deine Apotheke), the Warenverzeichnis WEB-Link promotional service (manufacturer product linking), and advertising forms for pharmaceutical companies targeting pharmacists and physicians.

apoverlag.at
6Training and Continuing Education
TypeFreemium
Description

Continuing education platforms (ApoVerlag Campus, ApoVerlag PKA Campus, Diagnosia Campus) offering free training content for pharmacists, PKA, and physicians, earning DFP/AFP/FFP certification credits. Some programs are free; others may be bundled into subscriptions.

apoverlag.at
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
Pricing details10 tiers
1ÖAZ – Österreichische Apotheker-Zeitung subscription: €179/year (excl. VAT, plus shipping)
ModelSubscriptionBilling cadenceAnnual
Notes

Biannual publication (14-day intervals), auto-renews unless cancelled 14 days before quarter end. Includes print and online access.

apoverlag.at
2Taxbehelf zur Österreichischen Arzneitaxe: €33.80 (excl. VAT)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Published twice yearly (January/July edition). Includes Kassenzeichen, Abgrenzungsverordnung, synonym index. Format: brochure spiral-bound, 21×29.7cm, ~114 pages.

shop.apoverlag.at
3Rezeptfreie Arzneispezialitäten nach Indikationsgruppen: €15.80 (excl. VAT)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Monthly availability. Spiral-bound, 210×297mm, 140g paper.

shop.apoverlag.at
4Gesamtvertrag Anlagen II & III: €31.20 (excl. VAT)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Annual edition 2026. Bound brochure, 297×210mm, 80g paper, 76 pages.

shop.apoverlag.at
5Spezialitäteninformation für die Apotheke: €64.50 (excl. VAT)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Spiral-bound, 210×297mm, 80g paper, 142 pages core.

shop.apoverlag.at
6Lagerungstemperaturen & Ablaufdatum: €42.00 (excl. VAT)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Published twice yearly (April 2026 edition). Wire-O-bound, 210×297mm, 80g, ~150 pages.

shop.apoverlag.at
7Liste rezeptfreier Arzneispezialitäten: €6.20/month (excl. VAT)
ModelSubscriptionBilling cadenceMonthly
Notes

Monthly availability. Brochure, 21×29.7cm, ~22 pages.

shop.apoverlag.at
8Tabellen für Arzneimittelzubereitungen (subscription): starting at €6.50 (excl. VAT)
ModelSubscriptionBilling cadenceAnnual
Notes

Subscription with updates upon each revision. Includes Arbeitspreise, Ergänzungstaxbehelf, Kalkulationstabellen, Taxansätze.

shop.apoverlag.at
9Diagnosia Enterprise: quote-based pricing
ModelSubscriptionBilling cadenceAnnual
Notes

Modular platform: Basic, Check, Grav&Lact, Allergy, Dose modules. Also available with optional add-ons: Hausliste, PV-Meldung, News. Stand-alone browser-based or integrated via REST-API/KIS/PDMS. Pricing requires consultation with sales team.

apoverlag.at
10AVS Software: quote-based pricing
ModelSubscriptionBilling cadenceAnnual
Notes

Austria's leading pharmacy software, individually customizable and modular. Pricing requires consultation; sold via Verkaufsabteilung.

apoverlag.at
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1ApoVerlag
Description

Brand providing complete solutions for Austrian pharmacies, including pharmacy software AVS, specialist media (ÖAZ, pka-Magazin, DA – Deine Apotheke), pharmaceutical data, print works, and digital solutions.

apoverlag.at
+2 more records
Core offering1 text field

APOVERLAG provides pharmaceutical information databases, pharmacy management software (AVS), clinical decision support platforms (Diagnosia Enterprise), and professional publishing for the Austrian healthcare sector. The company operates three brands—ApoVerlag, AustriaCodex, and Diagnosia—covering drugs, pricing references, clinical content, and digital workflows for pharmacies, physicians, hospitals, and pharmaceutical manufacturers. It also publishes the ÖAZ and pka-Magazin journals and offers continuing education (ApoVerlag Campus, Diagnosia Campus) for healthcare professionals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 90+ Austrian hospitals and nursing facilities rely on Diagnosia Enterprise daily
+3 more records
Product overview1 text field

APOVERLAG operates as a comprehensive pharmaceutical information and publishing company with three main brands: AustriaCodex (drug databases and reference materials), ApoVerlag (complete solutions for pharmacies), and Diagnosia (digital solutions for medical professionals). The portfolio includes core software products like AVS pharmacy software and Diagnosia Enterprise, pharmaceutical databases (Austria Codex Online, Warenverzeichnis, KHIX²), professional publications (ÖAZ journal, pka-Magazin, DA magazine), educational platforms (ApoVerlag Campus, Diagnosia Campus), print reference works (Taxbehelf, pharmaceutical handbooks), and digital tools (Apps, couponing, on-duty displays). The platform-plus-modules architecture is evident in Diagnosia Enterprise with its modular offering (Basic, Check, Allergy, Gravidität & Laktation, Dose modules) and AustriaCodex with its combinable database modules.

Product and service17 records
1Diagnosia Enterprise
CategoryClinical Decision Support Software
Description

Web-based evidence-based clinical decision support platform for hospitals and nursing facilities, providing drug Fachinformation, safety, dosages, treatment options, interaction checks, UAW analysis, pregnancy/lactation guidance, allergy cross-reaction checking, and dose adjustments for renal/hepatic impairment. Integrated via REST-API (JSON) or GET-parameter interfaces into hospital KIS/PDMS. Used by 90+ Austrian hospitals and nursing facilities with 7 million+ monthly data queries.

2Diagnosia App
CategoryMobile Clinical Reference App
Description

Mobile application providing fast medication search with specialist and reimbursement information overview, and drug interactions display. Targeted at physicians for daily clinical workflow use and explicitly does not collect patient health data.

3Diagnosia Campus
CategoryContinuing Education Platform
Description

Free continuing education platform for physicians featuring live webinars, e-learnings, podcasts, and DFP points collection.

4Austria Codex Online
5AVS Software
6ÖAZ – Österreichische Apotheker-Zeitung
7pka-Magazin
8DA – Deine Apotheke
9ApoVerlag Campus
10ApoVerlag PKA Campus
11ApoVerlag Couponing
12Warenverzeichnis (Article Directory)
13Spezialitäteninfo²
14AMSE Arzneischnellerkennung Online
15Taxbehelf
16ApoShop
17Warenverzeichnis WEB-Link
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or Integration
Description

Medbase (a Karolinska Institut spin-off, ISO-certified company based in Finland) is the primary data source for Diagnosia Enterprise's clinical decision support content. Medbase provides evidence-based drug safety, efficacy, and dosage information including interactions, UAW analysis, pregnancy/lactation guidance, allergy cross-reactions, and dose adjustments for renal/hepatic impairment. This data partnership forms the clinical core of Diagnosia Enterprise, used by 90+ Austrian hospitals.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

APOVERLAG works with certified software houses (SWH) to integrate Diagnosia Enterprise via REST-API (JSON format) or GET-parameter interfaces into hospital KIS (Hospital Information Systems) and PDMS (Patient Data Management Systems). Implementation follows a structured process: contract clarification, test account/token issuance, SWH-led integration, and go-live with user onboarding.

3Österreichischer Apothekerverband & VAAÖ (Parent Organizations)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

APOVERLAG is co-owned 50/50 by the Österreichischer Apothekerverband (Austrian Pharmacists Association – representing independent pharmacists) and the Verband Angestellter Apotheker Österreichs (VAAÖ – Association of Employed Pharmacists Austria). Both parent organizations are based at Spitalgasse 31, 1090 Vienna. They co-publish the ÖAZ journal and represent the professional interests of Austrian pharmacists.

apoverlag.at
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1DAKOS Datenkommunikations GmbH (DAKOS)
TypeDirect peer
Description

German provider of pharmacy management systems, PVS/Praxis and reimbursement solutions comparable to APOVERLAG's AVS Software and tax/pricing tools.

2Documed (Swiss Drug Compendium)
TypeRegional player
Description

Swiss pharmaceutical documentation firm operating the official Swiss drug reference (compendium.ch). Closely comparable as a national drug compendium and reference publisher for healthcare professionals.

TypeBroad incumbent
Description

Large European healthcare software incumbent offering pharmacy IT (e.g., PHARMACY, WinApothek), ePrescribing, hospital information systems and clinical decision support. Operates across DACH with broader portfolio and scale than APOVERLAG's pharmacy-focused stack.

4ifap Service-Institut für Ärzte und Apotheker
TypeDirect peer
Description

Provider of drug databases and clinical decision support tools used by physicians and pharmacies in Germany, including interaction checks and reference data. Direct comparable to Austria Codex and Diagnosia Enterprise offerings.

TypeDirect peer
Description

Germany-based publisher of pharmaceutical databases, clinical decision support and medication management software (e.g., ifap index, PharmaMMI). Direct competitor to APOVERLAG's Austria Codex and Diagnosia Enterprise products in DACH ePrescribing and medication workflow software.

6ID Information & Dokumentation im Gesundheitswesen
TypeEmerging player
Description

Provider of specialized drug information and CDSS tools that target hospital and pharmacy drug workflow use cases similar to Austria Codex KHIX² and Diagnosia Enterprise modules.

7Elsevier ClinicalPath / ClinicalKey Drugs
TypeBroad incumbent
Description

Elsevier's clinical decision support and drug reference portfolio (ClinicalKey, Gold Standard). Targets hospital drug information and formulary workflows parallel to Austria Codex KHIX² and Diagnosia Enterprise.

TypeBroad incumbent
Description

Global clinical decision support and drug reference vendor (Lexicomp, Medi-Span, UpToDate Lexidrug). Competes with Diagnosia Enterprise at the hospital CDS level and could enter Austrian hospital integrations.

9ABDATA Pharma-Daten-Service (ABDA)
TypeDirect peer
Description

Operator of Germany's central pharmaceutical article database (ABDA-Artikelstamm) used in pharmacy systems. Compares directly to APOVERLAG's Warenverzeichnis; APOVERLAG's AVS Software even integrates ABDA's article master as a Germany bridge.

TypeRegional player
Description

Swiss publisher of pharmaceutical indexing, drug information and pharmacy data (Index Therapeuticus, compendium.ch). Operates a model analogous to APOVERLAG's Austria Codex Warenverzeichnis but in the Swiss market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

APOVERLAG

Pharmaceutical Information & Pharmacy Softwareapoverlag.at

APOVERLAG is a Vienna-based, pharmacist-association-owned publishing and information services company (founded 1946) providing pharmacy software (AVS), clinical decision support for 90+ hospitals (Diagnosia Enterprise), pharmaceutical databases, professional journals, and continuing education to the Austrian healthcare sector.

What APOVERLAG does

APOVERLAG (legal name: Österreichische Apotheker-Verlagsgesellschaft m.b.H.) is a Vienna-based, privately held publishing and information services company serving the Austrian pharmaceutical sector. Founded in 1946 and jointly owned 50/50 by the Österreichischer Apothekerverband and the Verband Angestellter Apotheker Österreichs (VAAÖ), the company operates three brands—ApoVerlag, AustriaCodex, and Diagnosia—that collectively cover the pharmacy-to-physician-to-hospital value chain. Its core assets include AVS Software (Austria's leading pharmacy management system), Diagnosia Enterprise (a web-based clinical decision support platform serving 90+ hospitals and nursing facilities with 7M+ monthly data queries), and the Austria Codex Online pharmaceutical database covering 110,000+ drug articles.

The company's technology stack comprises cloud-hosted web applications and mobile apps integrating with hospital KIS/PDMS systems via documented REST-API (JSON) and GET-parameter interfaces. Diagnosia Enterprise sources clinical evidence from Medbase (a Karolinska Institut spin-off, ISO-certified), AGES, and EMA. The portfolio also includes professional journals (ÖAZ, pka-Magazin, DA – Deine Apotheke), continuing education platforms (ApoVerlag Campus, Diagnosia Campus), print reference works (Taxbehelf, Warenverzeichnis), the ApoShop e-commerce storefront, and the ApoVerlag Couponing system operating across 1,400+ pharmacy interfaces.

APOVERLAG generates revenue through six distinct streams: recurring database and software subscriptions (Austria Codex Online, Diagnosia Enterprise, AVS Software), software licenses and SaaS, print publications, direct e-commerce product sales via ApoShop, advertising in owned professional media, and freemium training/continuing education. Go-to-market combines direct-to-consumer self-service through ApoShop, in-house enterprise sales (Verkaufsabteilung) for AVS and Diagnosia Enterprise, certified software house partners for hospital integration, and the association ownership structure that delivers near-universal distribution across the Austrian pharmacy profession. The company serves four primary vertical segments—pharmacies, physician practices, hospitals, and pharmaceutical companies—exclusively within the Austrian domestic market.

APOVERLAG firmographics

Firmographics
Name
APOVERLAG
Legal name
Österreichische Apotheker-Verlagsgesellschaft m.b.H.
Website
https://apoverlag.at
Company type
Private
Founded year
1946
Operating status
Operating
Headcount range
51–100 employees
Short description
APOVERLAG is a Vienna-based, pharmacist-association-owned publishing and information services company (founded 1946) providing pharmacy software (AVS), clinical decision support for 90+ hospitals (Diagnosia Enterprise), pharmaceutical databases, professional journals, and continuing education to the Austrian healthcare sector.
Ownership category
akta.pro rank

APOVERLAG industry classification

Industry
Product category
Pharmaceutical Information & Pharmacy Software
NAICS
Software Publishers (51321)
akta.pro industry
PRIMARYHLALAIAD
ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALAIAG
Medication Adherence & Therapy Management Platforms (refills, reminders, MTM)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLACAKAN
Medication Pricing, Copay Assistance & Patient Financial Support Tools
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYMPAAAAAJ
Healthcare/Pharma Creative Agencies
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Advertising Agencies (Full-Service/Creative)

Keywords

  • Pharmaceutical information databases
  • Pharmacy management software
  • Clinical decision support systems
  • Medical publishing services
  • Healthcare professional education

Where APOVERLAG is headquartered

Location

Headquarters

HQ city
Breitenfurt Bei Wien
HQ country
Austria
HQ region
Europe

Offices1 record

Markets served

APOVERLAG business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Pharmaceutical Database Subscriptions: Subscription-based access to Austria Codex Online, Austria Codex KHIX², Warenverzeichnis Online, AMSE, and other pharma databases. Offered as modular, combinable subscriptions for pharmacies, hospitals, physician practices, and pharmaceutical companies. Revenue is recurring with periodic (monthly/annual) billing.
  2. Software Licenses and SaaS: Licensing of AVS Software (pharmacy management), Diagnosia Enterprise (clinical decision support), and AVS One App. Diagnosia Enterprise is offered as standalone or integrated solutions for hospitals, with tiered modules (Basic, Check, Grav&Lact, Allergy, Dose).
  3. Print Publications and Journals: Sale of pharmaceutical journals (ÖAZ – Österreichische Apotheker-Zeitung, appearing bi-weekly; pka-Magazin, appearing six times annually; DA – Deine Apotheke customer magazine), pharmaceutical reference works (Taxbehelf, Warenverzeichnis print editions, pharmaceutical handbooks), and prescription reference tables. Offered as subscriptions or individual purchases.
  4. eCommerce – Product Sales: Direct sales of pharmacy supplies, consumables, packaging, reference tables, handbooks, and pharmaceutical documentation through the ApoShop online store (shop.apoverlag.at). Includes one-time purchases and consumable restocking.
  5. Advertising and Promotion Services: Advertising and promotional placement in print journals (ÖAZ, pka-Magazin, DA – Deine Apotheke), the Warenverzeichnis WEB-Link promotional service (manufacturer product linking), and advertising forms for pharmaceutical companies targeting pharmacists and physicians.
  6. Training and Continuing Education: Continuing education platforms (ApoVerlag Campus, ApoVerlag PKA Campus, Diagnosia Campus) offering free training content for pharmacists, PKA, and physicians, earning DFP/AFP/FFP certification credits. Some programs are free; others may be bundled into subscriptions.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualÖAZ – Österreichische Apotheker-Zeitung subscription: €179/year (excl. VAT, plus shipping)
One time/ perpetual licensePay-as-you-goTaxbehelf zur Österreichischen Arzneitaxe: €33.80 (excl. VAT)
One time/ perpetual licensePay-as-you-goRezeptfreie Arzneispezialitäten nach Indikationsgruppen: €15.80 (excl. VAT)
One time/ perpetual licensePay-as-you-goGesamtvertrag Anlagen II & III: €31.20 (excl. VAT)
One time/ perpetual licensePay-as-you-goSpezialitäteninformation für die Apotheke: €64.50 (excl. VAT)
One time/ perpetual licensePay-as-you-goLagerungstemperaturen & Ablaufdatum: €42.00 (excl. VAT)
SubscriptionMonthlyListe rezeptfreier Arzneispezialitäten: €6.20/month (excl. VAT)
SubscriptionAnnualTabellen für Arzneimittelzubereitungen (subscription): starting at €6.50 (excl. VAT)
SubscriptionAnnualDiagnosia Enterprise: quote-based pricing
SubscriptionAnnualAVS Software: quote-based pricing

Go-to-market motion2 records

Distribution channels6 records

Marketing channels8 records

APOVERLAG product offering

Product offering

Core offering

APOVERLAG provides pharmaceutical information databases, pharmacy management software (AVS), clinical decision support platforms (Diagnosia Enterprise), and professional publishing for the Austrian healthcare sector. The company operates three brands—ApoVerlag, AustriaCodex, and Diagnosia—covering drugs, pricing references, clinical content, and digital workflows for pharmacies, physicians, hospitals, and pharmaceutical manufacturers. It also publishes the ÖAZ and pka-Magazin journals and offers continuing education (ApoVerlag Campus, Diagnosia Campus) for healthcare professionals.

Product overview

APOVERLAG operates as a comprehensive pharmaceutical information and publishing company with three main brands: AustriaCodex (drug databases and reference materials), ApoVerlag (complete solutions for pharmacies), and Diagnosia (digital solutions for medical professionals). The portfolio includes core software products like AVS pharmacy software and Diagnosia Enterprise, pharmaceutical databases (Austria Codex Online, Warenverzeichnis, KHIX²), professional publications (ÖAZ journal, pka-Magazin, DA magazine), educational platforms (ApoVerlag Campus, Diagnosia Campus), print reference works (Taxbehelf, pharmaceutical handbooks), and digital tools (Apps, couponing, on-duty displays). The platform-plus-modules architecture is evident in Diagnosia Enterprise with its modular offering (Basic, Check, Allergy, Gravidität & Laktation, Dose modules) and AustriaCodex with its combinable database modules.

Differentiator

Problem solved

Functional benefit

Brands

  • ApoVerlag: Brand providing complete solutions for Austrian pharmacies, including pharmacy software AVS, specialist media (ÖAZ, pka-Magazin, DA – Deine Apotheke), pharmaceutical data, print works, and digital solutions.
  • AustriaCodex
  • Diagnosia

Products and services

  • Diagnosia Enterprise Web-based evidence-based clinical decision support platform for hospitals and nursing facilities, providing drug Fachinformation, safety, dosages, treatment options, interaction checks, UAW analysis, pregnancy/lactation guidance, allergy cross-reaction checking, and dose adjustments for renal/hepatic impairment. Integrated via REST-API (JSON) or GET-parameter interfaces into hospital KIS/PDMS. Used by 90+ Austrian hospitals and nursing facilities with 7 million+ monthly data queries.
  • Diagnosia App Mobile application providing fast medication search with specialist and reimbursement information overview, and drug interactions display. Targeted at physicians for daily clinical workflow use and explicitly does not collect patient health data.
  • Diagnosia Campus Free continuing education platform for physicians featuring live webinars, e-learnings, podcasts, and DFP points collection.
  • Austria Codex Online
  • AVS Software
  • ÖAZ – Österreichische Apotheker-Zeitung
  • pka-Magazin
  • DA – Deine Apotheke
  • ApoVerlag Campus
  • ApoVerlag PKA Campus
  • ApoVerlag Couponing
  • Warenverzeichnis (Article Directory)
  • Spezialitäteninfo²
  • AMSE Arzneischnellerkennung Online
  • Taxbehelf
  • ApoShop
  • Warenverzeichnis WEB-Link

Quantifiable outcome

  • 90+ Austrian hospitals and nursing facilities rely on Diagnosia Enterprise daily
  • +3 more outcomes

Companies that use APOVERLAG

Customer profile

Named customers9 records

Segments5 records

Ideal customer profiles4 records

APOVERLAG technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability3 records

Feature8 records

APOVERLAG partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • MedbasecoreTechnology or IntegrationMedbase (a Karolinska Institut spin-off, ISO-certified company based in Finland) is the primary data source for Diagnosia Enterprise's clinical decision support content. Medbase provides evidence-based drug safety, efficacy, and dosage information including interactions, UAW analysis, pregnancy/lactation guidance, allergy cross-reactions, and dose adjustments for renal/hepatic impairment. This data partnership forms the clinical core of Diagnosia Enterprise, used by 90+ Austrian hospitals.
  • Software Houses (KIS/PDMS Integration Partners)coreImplementation/ SI/ Consulting PartnerAPOVERLAG works with certified software houses (SWH) to integrate Diagnosia Enterprise via REST-API (JSON format) or GET-parameter interfaces into hospital KIS (Hospital Information Systems) and PDMS (Patient Data Management Systems). Implementation follows a structured process: contract clarification, test account/token issuance, SWH-led integration, and go-live with user onboarding.
  • Österreichischer Apothekerverband & VAAÖ (Parent Organizations)coreStrategic or Co-development PartnerAPOVERLAG is co-owned 50/50 by the Österreichischer Apothekerverband (Austrian Pharmacists Association – representing independent pharmacists) and the Verband Angestellter Apotheker Österreichs (VAAÖ – Association of Employed Pharmacists Austria). Both parent organizations are based at Spitalgasse 31, 1090 Vienna. They co-publish the ÖAZ journal and represent the professional interests of Austrian pharmacists.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

APOVERLAG competitors and assessment

Company assessment

Direct peers

  • DAKOS Datenkommunikations GmbH (DAKOS): German provider of pharmacy management systems, PVS/Praxis and reimbursement solutions comparable to APOVERLAG's AVS Software and tax/pricing tools.
  • ifap Service-Institut für Ärzte und Apotheker: Provider of drug databases and clinical decision support tools used by physicians and pharmacies in Germany, including interaction checks and reference data. Direct comparable to Austria Codex and Diagnosia Enterprise offerings.
  • mmi Medizinische Medien Informations GmbH: Germany-based publisher of pharmaceutical databases, clinical decision support and medication management software (e.g., ifap index, PharmaMMI). Direct competitor to APOVERLAG's Austria Codex and Diagnosia Enterprise products in DACH ePrescribing and medication workflow software.
  • ABDATA Pharma-Daten-Service (ABDA): Operator of Germany's central pharmaceutical article database (ABDA-Artikelstamm) used in pharmacy systems. Compares directly to APOVERLAG's Warenverzeichnis; APOVERLAG's AVS Software even integrates ABDA's article master as a Germany bridge.

Regional players

  • Documed (Swiss Drug Compendium): Swiss pharmaceutical documentation firm operating the official Swiss drug reference (compendium.ch). Closely comparable as a national drug compendium and reference publisher for healthcare professionals.
  • HCI Solutions (Galexis/HDG-Data): Swiss publisher of pharmaceutical indexing, drug information and pharmacy data (Index Therapeuticus, compendium.ch). Operates a model analogous to APOVERLAG's Austria Codex Warenverzeichnis but in the Swiss market.

Broad incumbents

  • CompuGroup Medical (CGM): Large European healthcare software incumbent offering pharmacy IT (e.g., PHARMACY, WinApothek), ePrescribing, hospital information systems and clinical decision support. Operates across DACH with broader portfolio and scale than APOVERLAG's pharmacy-focused stack.
  • Elsevier ClinicalPath / ClinicalKey Drugs: Elsevier's clinical decision support and drug reference portfolio (ClinicalKey, Gold Standard). Targets hospital drug information and formulary workflows parallel to Austria Codex KHIX² and Diagnosia Enterprise.
  • Wolters Kluwer Clinical Solutions (Lexicomp/UpToDate/Medi-Span): Global clinical decision support and drug reference vendor (Lexicomp, Medi-Span, UpToDate Lexidrug). Competes with Diagnosia Enterprise at the hospital CDS level and could enter Austrian hospital integrations.

Emerging players

  • ID Information & Dokumentation im Gesundheitswesen: Provider of specialized drug information and CDSS tools that target hospital and pharmacy drug workflow use cases similar to Austria Codex KHIX² and Diagnosia Enterprise modules.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

APOVERLAG social profiles

Digital presence

APOVERLAG financial estimates

Financial estimate

Revenue estimate

Valuation estimate

APOVERLAG leadership team

Management profile

Number of profiles

Profiles4 records

APOVERLAG funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

APOVERLAG M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about APOVERLAG

What does APOVERLAG do?

APOVERLAG provides pharmaceutical information databases, pharmacy management software (AVS), clinical decision support platforms (Diagnosia Enterprise), and professional publishing for the Austrian healthcare sector. The company operates three brands—ApoVerlag, AustriaCodex, and Diagnosia—covering drugs, pricing references, clinical content, and digital workflows for pharmacies, physicians, hospitals, and pharmaceutical manufacturers. It also publishes the ÖAZ and pka-Magazin journals and offers continuing education (ApoVerlag Campus, Diagnosia Campus) for healthcare professionals.

Is APOVERLAG a public or private company?

APOVERLAG is a private company. It is classified as corporate owned and is currently operating.

When was APOVERLAG founded?

APOVERLAG was founded in 1946. It employs 51 to 100 people.

Where is APOVERLAG based?

APOVERLAG is headquartered in Breitenfurt Bei Wien, Austria, in the Europe region.

How does APOVERLAG make money?

Six revenue lines are on record. Pharmaceutical Database Subscriptions are the primary driver. The others are software Licenses and SaaS, print Publications and Journals, eCommerce – Product Sales, advertising and Promotion Services and training and Continuing Education.

Who are APOVERLAG's main competitors?

Direct peers on record are DAKOS Datenkommunikations GmbH (DAKOS), ifap Service-Institut für Ärzte und Apotheker, mmi Medizinische Medien Informations GmbH and ABDATA Pharma-Daten-Service (ABDA). Regional players are Documed (Swiss Drug Compendium) and HCI Solutions (Galexis/HDG-Data). Broad incumbents are CompuGroup Medical (CGM), Elsevier ClinicalPath / ClinicalKey Drugs and Wolters Kluwer Clinical Solutions (Lexicomp/UpToDate/Medi-Span). ID Information & Dokumentation im Gesundheitswesen is listed as an emerging player.

Does APOVERLAG have an API?

Yes. REST-API JSON Format-Schnittstelle zur Integration in KIS/PDMS-Systeme. Diagnosia Enterprise offers a unidirectional documented interface for direct access to the web interface from KIS/PDMS systems via GET parameters, as well as a REST-API JSON format interface for integration with hospital information systems. Technical documentation available at docs.diagnosia.com (password-protected area for interface solution). Developer documentation is at docs.diagnosia.com/login.

What industry is APOVERLAG in?

APOVERLAG's product category is Pharmaceutical Information & Pharmacy Software. Its primary akta.pro industry code is HLALAIAD, ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history), with a secondary code of HLALAIAG, Medication Adherence & Therapy Management Platforms (refills, reminders, MTM). Its NAICS code is 51321.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales